Prasita A 10mg Capsule

Prasita A 10mg Capsule is a dual antiplatelet therapy (DAPT) designed to prevent heart attacks, strokes, and other cardiovascular complications in high-risk patients. This combination brings together Aspirin, a well-known antiplatelet agent, and Prasugrel, a P2Y12 inhibitor that works through a complementary mechanism to inhibit platelet aggregation.

• Aspirin (75 mg): Inhibits platelet activation via the COX-1 pathway, preventing blood clot formation in arteries.

• Prasugrel (10 mg): Blocks ADP-mediated platelet activation, providing a more potent antiplatelet effect.

This therapy is commonly prescribed for patients with acute coronary syndrome (ACS), those undergoing percutaneous coronary intervention (PCI), or individuals at high risk of recurrent cardiovascular events. By targeting multiple pathways of platelet aggregation, it provides enhanced protection against thrombotic events compared to Aspirin alone.